Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge

Jessica K. Paulus, Kari E. Roberts

Source: Eur Respir J 2013; 41: 1014-1016
Journal Issue: May
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jessica K. Paulus, Kari E. Roberts. Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge. Eur Respir J 2013; 41: 1014-1016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
Source: Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017
Year: 2017



Leukotriene-mediated sex dimorphism in pulmonary arterial hypertensionmonocrotaline-induced rat.
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension
Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018
Year: 2018



Sex matters in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 553-554
Year: 2014


Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model.
Source: International Congress 2017 – Experimental PH
Year: 2017

Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
Source: Eur Respir J, 53 (6) 1801524; 10.1183/13993003.01524-2018
Year: 2019



Autoimmunity and pulmonary arterial hypertension: The role of leptin
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Sex and haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 523-530
Year: 2013



Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Source: Eur Respir J 2013; 41: 1466-1467
Year: 2013


Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Source: Eur Respir J 2013; 41: 1465-1466
Year: 2013


Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010


Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects
Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016
Year: 2017



Sex differences in the relation between sex hormones and right ventricular function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020




Systemic consequences of pulmonary arterial hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019


The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005

The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014